LTBK-04 FIRST RESULTS OF THE RANDOMIZED PHASE II STUDY ON DEPATUX –M ALONE, DEPATUX-M IN COMBINATION WITH TEMOZOLOMIDE AND EITHER TEMOZOLOMIDE OR LOMUSTINE IN RECURRENT EGFR AMPLIFIED GLIOBLASTOMA: FIRST REPORT FROM INTELLANCE 2/EORTC TRIAL 1410-Reference-Cited by-同舟云学术

LTBK-04 FIRST RESULTS OF THE RANDOMIZED PHASE II STUDY ON DEPATUX –M ALONE, DEPATUX-M IN COMBINATION WITH TEMOZOLOMIDE AND EITHER TEMOZOLOMIDE OR LOMUSTINE IN RECURRENT EGFR AMPLIFIED GLIOBLASTOMA: FIRST REPORT FROM INTELLANCE 2/EORTC TRIAL 1410

Published:2017-11 Issue:suppl_6 Volume:19 Page:vi316-vi316
ISSN:1522-8517
Container-title:Neuro-Oncology
language:en
Short-container-title:

Author:

van den Bent Martin,Eoli Marica,Sepulveda Juan Manuel,Smits Marion,Walenkamp Annemiek,Frenel Jean-Sebastien,Brandes Alba A,Clement Paul,French Pim,Dubbink Hendrikus,Kros Johan,Weller Michael,Chinot Olivier,de Vos Filip,Whenham Nicolas,Sanghera Paul,Looman Jim,Lee Ho-Jin,de Geus Jan-Peter,Nuyens Sarah,Spruyt Maarten,Brilhante Joana,Gorlia Thierry,Golfinopoulos Vassilis

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Neurology (clinical),Oncology

Link

http://academic.oup.com/neuro-oncology/article-pdf/19/suppl_6/vi316/21797761/nox213.pdf

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody Drug Conjugates in Glioblastoma – Is There a Future for Them?;Frontiers in Oncology;2021-12-03

2. Treatment options for progression or recurrence of glioblastoma: a network meta-analysis;Cochrane Database of Systematic Reviews;2021-01-05

3. Epidermal growth factor receptor (EGFR) amplification rates observed in screening patients for randomized trials in glioblastoma;Journal of Neuro-Oncology;2019-07-04

4. Epidermal growth factor receptor and ligand family expression and activity in glioblastoma;Journal of Neurochemistry;2018-08-16

5. Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients withEGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial;Neuro-Oncology;2018-07-05